title: Tuberculous peritonitis in a patient with rheumatoid arthritis treated with adalimumab.
abstract: We present a case of tuberculous peritonitis in a 71-year-old woman with long-standing rheumatoid arthritis treated with adalimumab, and we review the association between antitumor necrosis factor therapy and tuberculosis. Our case illustrates that the index of suspicion of tuberculosis in these patients, even with atypical clinical features, must be very high, and underscores the need of tuberculosis screening before therapy is started.
authors.affiliation: Internal Medicine Department, Hospital de Basurto, Avenida de Montevideo, 18, 48013 Bilbao, Spain. alguma@teleline.es
authors.forename: Alfonso
authors.initials: A
authors.lastname: Gutiérrez-Macías
authors.forename: Eva
authors.initials: E
authors.lastname: Lizarralde-Palacios
authors.forename: Pedro
authors.initials: P
authors.lastname: Martínez-Odriozola
authors.forename: Felipe
authors.initials: F
authors.lastname: Miguel-de la Villa
mesh_terms: D000068879:Adalimumab; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D010538:Peritonitis / Q000382:microbiology*; D014376:Tuberculosis / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C439524:TNF protein, human; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab